Severity-Dependent Neuroaxonal Damage Assessed by Serum Neurofilaments in ICANS Patients Undergoing CD19-Targeted CAR T-Cell Therapy (P1-8.001)

Our goal is to investigate the serum neurofilament light chain (NfLs) dynamics related to the presence of ICANS and its severity.

Authors

Institutions

Publication Details

Journal
Neurology
Published
2025-04-07
DOI
https://doi.org/10.1212/wnl.0000000000211719
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Severity-Dependent Neuroaxonal Damage Assessed by Serum Neurofilaments in ICANS Patients Undergoing CD19-Targeted CAR T-Cell Therapy (P1-8.001)

Andreu Vilaseca-Jolonch, Samantha Feijóo, Helena Ariño, Xavier Montalbán et al.
Neurology
CAR-T cell therapy research
article

Severity-Dependent Neuroaxonal Damage Assessed by Serum Neurofilaments in ICANS Patients Undergoing CD19-Targeted CAR T-Cell Therapy (P1-8.001)

Andreu Vilaseca-Jolonch, Samantha Feijóo, Helena Ariño, Xavier Montalbán, Gloria Iacoboni, Cecilia Carpio, Mar Tintoré, Ana Zabalza, Pere Barba, Ángela Vidal‐Jordana, María Jesús Arévalo, Mario Sánchez
article en

Abstract

Our goal is to investigate the serum neurofilament light chain (NfLs) dynamics related to the presence of ICANS and its severity.

NeurologyVol. 104(7_Supplement_1)
Hebron University (PS)
Good health and well-being
Openalex Percentile: Top 90%
CAR-T cell therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Severity-Dependent Neuroaxonal Damage Assessed by Serum Neurofilaments in ICANS Patients Undergoing CD19-Targeted CAR T-Cell Therapy (P1-8.001) — Andreu Vilaseca-Jolonch, Samantha Feijóo, et al. · Neurology (2025) | TGRS Research Map | TGRS